Stargardt disease: clinical studies over the past 5 years—a systematic review
Although STGD1 remains a challenging condition, new therapies in this review have shown potential in clinical trials, even though challenges such as off-target effects and DNA repair errors remain.
Tarik Badi-Mustafa, E. Moser, Carmen Perales et al.
· Spektrum der Augenheilkunde · 0 citations